Patent ID: 7598392

Claim:
A compound of formula (I): in which: R 1 represents a hydrogen or halogen atom, a (C 1 -C 4 )alkyl, trifluoro(C 1 -C 4 )alkyl, hydroxyl, (C 1 -C 4 )alkoxy, trifluoro(C 1 -C 4 )alkoxy, (C 3 -C 10 )cycloalkyl(C 1 -C 4 )alkoxy, (C 3 -C 10 )cycloalkyloxy, allyloxy or (C 1 -C 4 )alkylthio group; R 2 represents a hydrogen or halogen atom, a hydroxyl, (C 1 -C 4 )alkyl, trifluoro(C 1 -C 4 )alkyl, perfluoro(C 1 -C 4 )alkyl, (C 3 -C 10 )cycloalkyl, (C 1 -C 4 )alkoxy, (C 3 -C 10 )cycloalkyl(C 1 -C 4 )alkoxy, (C 3 -C 10 )cycloalkyloxy, allyloxy or (C 3 -C 8 )cycloalkyl(C 1 -C 4 )alkyl group; Y represents a hydrogen atom or a halogen; R 3 represents: a phenyl group substituted with one or more: fluorine, bromine, iodine, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, (C 1 -C 6 )alkoxy, —NO 2 , cyano, —COR 4 , —SO 2 R 4 , —CO 2 R 4 , in which R 4 represents a (C 1 -C 4 )alkyl group, or —(CH 2 ) q NR 5 R 6 , in which R 5 and R 6 represent, independently of each other, a hydrogen atom or a (C 1 -C 4 )alkyl group or R 5 and R 6 form, together with the nitrogen atom to which they are attached, a 5- or 6-membered cycloalkyl group and q represents 0, 1 or 2; or R 3 represents a heterocyclic group optionally substituted with one or more: halogen, (C 1 -C 4 )alkyl, hydroxyl, (C 1 -C 4 )alkoxy, cyano, morpholine, trifluoro(C 1 -C 4 )alkyl, —COR 4 , —SO 2 R 4 , in which R 4 is as defined hereinabove, —(CH 2 ) q NR 5 R 6 , in which R 5 , R 6 and q are as defined hereinabove, phenyl, pyridine, or —SCH 3 ; the nitrogen atom(s) of the heterocyclic groups which comprise a nitrogen atom(s) may be optionally substituted with a (C 1 -C 4 )alkyl group, the nitrogen atom(s) of the heterocyclic groups which comprise a nitrogen atom(s) may be optionally in the N-oxide form; or R 3 represents a heterobicyclic group optionally substituted with one or more halogen, hydroxyl, (C 1 -C 4 )alkyl or (C 1 -C 4 )alkoxy groups; m represents 2, 3 or 4; n represents 0, 1 or 2; p represents 0, 1, 2 or 3; or an addition salt of said compound with a pharmaceutically acceptable acid; or a racemic mixture, enantiomer, diastereoisomer or mixture thereof of said compound or said salt.